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RelaSonship between use of intravenous aminoglycosides and renal 
funcSon in CF patients 
M. Marol i  1, H. Talbot 1, S. Marrb 1, S. Elworthy 1"~, B. Patel 1, P. Oader 2, C. Sheldon 1, 
N. Withers 1
~Departrnent of Respiratory Medicine, 2Department of Paediatrics, Royal Devon & 
Exeter Hospital, UK 
Baekgmtmd:  Recently there hat been increaring concern regarding the possible 
association of renal impairment and repeated IV aminoglycoride use. We tmdert oak 
a retr orpective study to assess the rignif icance of this in CF patients under our care. 
Methods:  Calculated CYeatinine clearance war ured ar an index of renal function 
derived from the Ccdffroft Ganlt formula for adults mad the Schwartz formula for 
adolescents. Data from the last annual review war ured and recordr were examined 
to arcertain the total number of days of IV aminoglycoride or colirtin each patient 
received in the preceding 3 yearr. 
Resulrs: 45 patients with CF (35 adults & 10 adolescents) were included in the 
rtudy, mean age 26yrr (range12 66), and mean pred FEV1 58% (range13 106). 
Using a multiple l inear regrerrion model, renal function war compared with the 
number of days of IV aminoglycoride and col irt in in the preceding 3 yearr. There 
war a rignificant correlation between IV antibiotic ure and diminirbing renal 
function (r 0.36, p <0.02). Thir effect war independent of FEV 1, NSAID ure and 
diabeter. 
Only 4 patients had a C¥ CI <80ml/min i dicating a degree of renal impairment. The 
2 lowest values were in a patient who war  on immtmorupprer r ive therapy fol lowing 
tr anrplant ation and ha a patient with poorly controlled iabeter. 
Discussion: Thir study demonrtrater a rignificant inverre relationship between 
creatinine clearance mad the ure of IV aminoglycorider. However, in cl inical 
practice rignificant renal impairment doer not seem to be a problem in our 
population of CF patients although with improvements in rurvival and increaring 
courter of aminoglycorider this may become a rignificant problem in the future. 
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Cumulative nephrotoxic effect of IV aminoglycoside therapy in CF 
M. AI Aloul,  H. Miller, M.J. Ledr on, M.J. Walrbaw 
Adult CF Unit, The CaMiothoracic Centre, Liverpool, UK 
IV  aminoglycoride (AG) courter ured to treat chert exacerbations in CF may be 
given at rbort ime intervalr for cl inical rearonr, potentially adding to the known 
cumulative toxic effect on renal tubular function. 
To rtudy thir, we mearured tubular cell enzymer (NAG and AAP) and protein (B2 
micr oglobulin) in ur ine in 34 adult CF patient r at bareline, after 14 dayr therapy and 
then weekly during 2 conrecutive exacerbationr treated with IV AG. BMI, U&E and 
creatinine clearance did not differ between epiroder. Patientr eceived the tame 
dare of AG and achieved rimilar therapeutic trough and peak rerum levelr each 
courre. 
Urinary markerr but not U&E rare with the 13 AG courre and ha 20 patientr 
recovered completely (achieved by week 7 [median 3, range 1 7]) prior to 2nd AG 
treatment (given to recovered group at median interval 14 weeks [range 11 16]; 
unrecovered group (14 patient r ), 5 weeks [3 7]). Fol lowing the 2 ~ treatment, in the 
recovered group the r i te  ha tubular markerr were comparable to the l r t  treatment 
(mean changer [13 v 2~]: NAG 0.51 v 0.48, AAP  2.10 v 2.30, B2  microglobulin 
0.66 v 0.72; all P INS) .  In the unrecovered group the rerum creatinine rare with the 
2nd treatment (9.4% from bareline, p<0.05) but did not croft the normality 
threrhold, and marker changer were greater than those obrerved ha the 1 ~t reatment 
(NAG 0.43 v 0.90, AAP 1.70 v 2.54, B2 microglobulin 0.81 v 1.21; all P<0.001). 
Also, return to baseline war slower after the 2nd treatment (median 6 weeks; range 
1 8). 
Thur, frequent IV AG therapy results in cumulative acute renal tubular toxicity, 
resolution of which may be protracted. We tugger t that alternative antipseudomonal 
antibiotic lasses are rotated in the management of frequent exacerbatorr ("AG 
breaks") whilst maintaining rurveil lance for AG nephrot oxicity. 
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Cystic Fibrosis and Acute Renal Failure: Case Series (SCARF Project) 
C.J. Bet tenrhaw 1,A.R. Watson 2, S. Lewis 3, I. Choonar a4, A.R. Smyth 1 
iDepartment of Chin Health, University of Nottingham, 2Department of 
Paediatrics, Nottingham City Hospital, 3Academic Division of Respiratory 
Medicine, University of Nottingham, 4Academic Division of Chin Health, 
Derbyshire ChiNren's Hospital 
Aims:  To determine the frequency of acute renal fai lure (ARF) in cyrtic f ibrorir 
(CF) patient r in the U.K. and par rible aetiological factorr. 
Methods:  We arked all cl inicianr working at a UK  CF Centre i f  they had been 
involved with the management of a patient with CF who had developed ARF and ha 
what year the patient prerented. Thore rerponding porit ively were arked to requer t 
informed content for entry into the rtudy. The patient'r care noter were then 
reviewed by a rerearcher. 
Results: There war a 98% centre rerponre rate. Since 1997 64 caret were reported 
prerenting with ARF. We report here on the f irrt 25 caret recruited. The median age 
at prerentation with ARF war  9 yearr 7 monthr and 11 caret are male. In 22 caret 
(88%) an aminoglycoride war prercribed at the t ime of onret of ARF or ha the 
preceding week. Aminoglycorider were mort commonly given in a three t imer daily 
dare and urually prercribed with ceilazidime. A renal biopry war  performed ha 8 
caret. In 5 thir thawed acute tubular necrorir, each of there caret had received 
gent amicin. Renal replacement therapy war  required ha 13 caret (52%). In 19 caret 
(76%) drug toxicity war  felt to be the primary caure of ARF, ha 6 caret there war  
an additional or alternative diagnosis. Mort  patient r (92%) had a good outcome with 
normal blood prerrure and rerum creatinine at tbree monthr. 
Conclusions: There ir a rignificant incidence of ARF ha patientr with CF. 
Aminoglycoride toxicity ir  the mort common caure. We wi l l  undertake a case 
controlled rtudy to elucidate the aetiology of acute renal fai lure in the CF 
population. 
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Relevance of specific airway resistance (sRAW) in pre-school 
children with cystic fibrosis 
D. Car tantini:, E. Bucchioni 2, M. Rurro:,  G. Romano:, A. Brivio:, C. Colombo: 
ICF Center am] 21nstitute of Lung Disease, University of Mila~ Milan, Italy 
Repir at ory function in young children ir difficult o evaluate and bert procedurer are 
not wel l  defined. 
A ims:  To evaluate the urefulnerr  of rpecific airway resistance (rRaw) mearured 
with pletirmography in the monitoring of CF related lung direase and to compare 
there valuer with thore obtained in healthy children. 
Methods:  We rtudied 37 pre rchool children with CF (mean age: 5.8+1.2 yr, 15 
maler) mad 18 wel l  matched healthy children (mean age 5.6+0.88 yr, 6 maler). Ten 
CF patientr (27%) were cbr onically colonired by Preudomonar aeruginor a (Pa). 
Mearurementr were carried out ur ing a conrtant volume whole body pletir mograph 
(Matter Screen Body 4.3; Erich Jaeger GmbH, Germany). 
Results: rRaw were rignif icantly higher in CF patientr (1.51+0.47 kPa*r) than in 
controlr (1.0+0.15, p<0.e(D5); there were no rignificant differencer in the other 
rpirometric par ameter r between the two gr oupr. 
CF patientr not colonired by Pa thawed rignificantly different rpirometric mad 
pletirmographic measurementr compared to cbronically colonized patientr: FEV 1 
(1.12 +0.23 L vr 0.91+0.14, p<0.05), FEF~0 (1.65+0.58 L/r vr 1.14+0.35, p<0.02), 
FEF,~ (0.84+0.40 L/r vr 0.46+0.21, p<0.01), rRaw (1.40+0.39 kPa*r vr 1.8+0.58 
p<0.02), rGaw (0.75+0.17 l /kPa*vr 0.59+0.19, p<0.02). 
Conclusions: our data provide evidence of the urefulnerr  of rRaw for early 
detection of lung impairment; hir tert ir  particularly ruitable for young children 
with CF rince it requirer minimal  co operation and no redation. 
